An ageing study of twenty 18650 lithium-ion Graphite/LFP cells in first and second life use.

Sci Data

Universite Claude Bernard Lyon 1, Ampère, UMR5005, INSA Lyon, Ecole Centrale de Lyon, CNRS, F-69100, Villeurbanne, France.

Published: March 2025

The dataset gives a comprehensive data collection focusing on the ageing of twenty 18650 Graphite/LFP 1.1 Ah commercial cells in first and second life. The ageing from a pristine state up to 40% of capacity loss is uncommon due to the extensive testing time required. Therefore, this new data collection provides insights on long-term ageing of lithium-ion batteries. The initial aim of the study was to comprehend the ageing in first and second-life applications, with a special focus on the sudden acceleration of capacity loss that can occur after a long-term use. The ageing experiment was designed to assess the impact of various test conditions: electric vehicle use, high current charge and discharge, full or partial discharge and a reduced operating voltage window. The cells were characterised every 100 cycles to measure the remaining capacity and the pseudo-open-circuit-voltage. This dataset can help the research community in studying second-life applications or any other study on long-term ageing of Graphite/LFP batteries: new diagnosis and prognosis techniques, AI, battery modelling, and more.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11885844PMC
http://dx.doi.org/10.1038/s41597-025-04712-7DOI Listing

Publication Analysis

Top Keywords

long-term ageing
12
twenty 18650
8
cells second
8
second life
8
data collection
8
capacity loss
8
second-life applications
8
ageing
7
ageing study
4
study twenty
4

Similar Publications

Objectives: to evaluate health gains sensitive to nursing care in the context of long-term home care.

Methods: this was a quantitative, retrospective study carried out in the north of Portugal. The sample consisted of 151 users aged 18 or over.

View Article and Find Full Text PDF

Purpose: This study analyzed the long-term effects of cancer on the health-related quality of life (HRQOL) of older breast cancer survivors for 10 years, including a control group to distinguish between the impacts of cancer treatment and aging.

Methods: The SEER-MHOS data resource was used in the analysis. Cases were 674 older women diagnosed with breast cancer in 1998-2015 at age 65 and older and participated in Medicare Health Outcomes Survey within 24 months before their cancer diagnosis and at least once within 10 years of post-diagnosis.

View Article and Find Full Text PDF

Transient receptor potential ankyrin 1 (TRPA1) is a sensory channel expressed in vagal afferent nerves that detect noxious stimuli. Trpa1 knockout accelerates age-related cardiac fibrosis and dysfunction in mice. This study investigated whether TRPA1 activation with its selective agonist, allyl isothiocyanate (AITC), prevents cardiac aging.

View Article and Find Full Text PDF

Importance: Frailty assessed at a single time point is associated with mortality in older women with breast cancer. Little is known about how changes in frailty following cancer treatment initiation affect mortality.

Objective: To evaluate the association between claims-based frailty trajectories following adjuvant chemotherapy initiation and 5-year mortality in older women with stage I to III breast cancer.

View Article and Find Full Text PDF

Immunosenescence, age-related immune dysregulation, reduces immunity upon vaccinations and infections. Cytomegalovirus (CMV) infection results in declining naïve (T) and increasing terminally differentiated (T) T cell populations, further aggravating immune aging. Both immunosenescence and CMV have been speculated to hamper the formation of protective T-cell immunity against novel or emerging pathogens.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!